Published: 27 May 2020
ID: G00720522
Analyst(s): Michael Shanler , Jeff Smith , Animesh Gandhi , Seth Feder
Life science companies are increasingly looking to technology-based innovation to drive R&D pipelines, digital capabilities, novel therapies and new commercial engagement models. CIOs should consider these new, disruptive vendors that are poised to help accelerate life science business results.
Overview
Analysis
Gartner Recommended Reading
©2021 Gartner, Inc. and/or its affiliates.
All rights reserved.
Gartner is a registered trademark of Gartner, Inc. and its affiliates.
This publication may not be reproduced or distributed in any form without Gartner’s prior written permission.
It consists of the opinions of Gartner’s research organization, which should not be construed as statements of fact.
While the information contained in this publication has been obtained from sources believed to be reliable, Gartner disclaims all warranties as to the accuracy, completeness or adequacy of such information.
Although Gartner research may address legal and financial issues, Gartner does not provide legal or investment advice and its research should not be construed or used as such.
Your access and use of this publication are governed by Gartner’s Usage Policy.
Gartner prides itself on its reputation for independence and objectivity.
Its research is produced independently by its research organization without input or influence from any third party.
For further information, see Guiding Principles on Independence and Objectivity.